2023 CME Credits & Contact Hours


ATMRD 2023 is jointly provided by Postgraduate Institute for Medicine and Parkinson & Movement Disorder Alliance.

Commercial Support

This activity has been supported by independent medical education grants from Abbott, AbbVie, GE HealthCare, Kyowa Kirin, Medtronic, and Merz.

This activity is also supported by in-kind contributions from Abbott, AbbVie, Ambu, Boston Scientific, Cadwell Industries, Medtronic, Merz, and Supernus.

Target Audience

This course is for movement disorder specialists, neurologists, advanced practice providers, and other healthcare professionals involved in the care of patients with a movement or related disorder.

Educational Objectives 

After completing this activity, the participant should be better able to: 

  • Appraise the newest research and guidelines for treating and managing movement disorders. 
  • Understand the value and importance of comprehensive interdisciplinary care in movement disorders and how to develop and define team roles and competencies. 
  • Interpret motor and non-motor fluctuations in Parkinson’s and related disorders. 
  • Differentiate treatments for motor and non-motor symptoms in Parkinson’s and related disorders, including impacts on patient quality of life and outcomes.   
  • Employ appropriate and routine screening, examination, and interviews with movement disorder patients and caregivers to assess symptoms, adverse interactions, disease progression, and quality of life.   
  • Minimize symptoms, side effects, and adverse interactions for patients diagnosed with a movement disorder.   
  • Implement advanced therapies in treating motor and non-motor symptoms of Parkinson’s and related disorders.  
  • Manage treatment plans, complex polypharmacy, calculation of dose, titration, and effective programming of devices as appropriate to maximize quality of life and improve patient outcomes. 

Joint Accreditation Statement 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PMD Alliance.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Speakers on the cutting edge. #ATMRD2023

ATMRD 2023 Course Directors

Fernando Pagan, MD, Course Director
Yasar Torres-Yaghi, MD, Course Director

Speakers on the cutting edge. #ATMRD2023

ATMRD 2023 Congress Faculty

Anvi Gadani, MD
Charbel Moussa, MBBS, PhD
David Shprecher, DO Msci, FAAN
Fahd Amjad, MD, MS
Fiona Gupta, MD
Jill M. Farmer, DO, MPH
Laxman Bahroo, DO, MS
Luke Lovelace
Mindy Bixby, D.O.
Pamela R Zeilman, NP
R. Scott Turner, PhD, MD, FANA, FAAN
Ramamohana Jonnala, RPh, PhD
Richard Dewey, MD
Safia Abdillahi, ACNP-BC, DNP
Steven E. Lo, MD
Stuart H. Isaacson, MD


APProviders™ Pre-Congress 2023 Course Directors

Kelly Papesh, MSN, DNP-C
Sherrie Gould, MSN, NP-C

APProviders™ Pre-Congress 2023 Faculty

Andrew Imbus, PA-C
Arita McCoy, MSN, CRNP
Jacqueline Cristini, PA-C, MMSc.
Juliana Nkea Atem, NP-C
Meredith Hatcher, PA-C
Mohamed Elkasaby, MD
Nasrin Esnaashari, DNP, CNS, NP-C, CCRN
Patrick Walker, NP-C
Priya Chaudhari, FNP-C
Shannon Shaffer, APRN-CNP

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.

The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

Credit Designation

Physician Continuing Medical Education 

The Postgraduate Institute for Medicine designates this activity for a maximum of 17.75 AMA PRA Category 1 Credit(s)™.   

Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Associate/Assistant Continuing Medical Education 

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 17.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

Continuing Nursing Education 

The maximum number of hours awarded for this Continuing Nursing Education activity is 17.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.

Request for Credit

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity: 

  1. Go to www.cmeuniversity.com 
  2. Login or Create a New Account (will take less than 1 minute) 
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email 
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page 
  3. While logged in, go to: https://www.cmeuniversity.com/multisession/12096
  4. Choose the type of credit you desire 
  5. Complete the online Evaluation 
  6. Receive an immediate CE Certificate to download and/or print for your files 

If you have questions regarding the certification of this activity, please contact PIM via email at [email protected] or PMD Alliance at [email protected]  

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.